MDMA ("Ecstasy"), Post-Traumatic Stress Disorder (PTSD), Psychotherapy & MAPS | Berra Yazar-Klosinski | #26
Send us a text
Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
Support the show
All episodes (audio & video), show notes, transcripts, and more at the M&M Substack
Affiliates:
Learn all the ways you can support my efforts
Create your
podcast in
minutes
It is Free